Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB<sub>2</sub> receptor.

Patel, Monica; Grimsey, Natasha L; Banister, Samuel D; Finlay, David B; Glass, Michelle

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB₂ receptor.

Patel, Monica; Grimsey, Natasha L; Banister, Samuel D; Finlay, David B; Glass, Michelle.

Afiliação

Patel M; Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand.
Grimsey NL; Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Banister SD; Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, University of Sydney, New South Wales, Australia.
Finlay DB; School of Chemistry, Faculty of Science, University of Sydney, New South Wales, Australia.
Glass M; Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand.

Pharmacol Res Perspect ; 11(6): e01157, 2023 Dec.

Article em En | MEDLINE | ID: mdl-38018694

Assuntos

Agonistas de Receptores de Canabinoides; Canabinoides; Humanos; Agonistas de Receptores de Canabinoides/farmacologia; Agonistas de Receptores de Canabinoides/química; Receptores de Canabinoides; Ligantes; Células HEK293; Canabinoides/farmacologia

Palavras-chave

THC; agonist bias; cannabinoid CB2 receptor; cell signaling; synthetic cannabinoid receptor agonist

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canabinoides / Agonistas de Receptores de Canabinoides Limite: Humans Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Nova Zelândia País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google